Application of interferon-γ release assay in immunocompromised patients with pulmonary tuberculosis / 中国免疫学杂志

ABSTRACT

Objective:To investigate the application value of interferon-γ release assay ( IGRA ) in immunocompromised patients with pulmonary tuberculosis. Methods:180 cases were chose including immunocompromised patients,pulmonary tuberculosis patients,immunocompromised patients with pulmonary tuberculosis and healthy volunteers to undergo IGRA in order to determine and compare the content of specific interferon-γ( IFN-γ) in plasma. At the same time, the result of immunocompromised patients with pulmonary tuberculosis was compared with tuberculin skin test (TST). Results:180 cases of the list were tested,included 40 immuno-compromised patients ( group A ) , 50 pulmonary tuberculosis patients ( group B ) , 40 immunocompromised patients with pulmonary tuberculosis patients(group C),and 50 cases in healthy control group(group D). The median of specific IFN-γ contents in the four groups were respectively 0. 112,7. 835,5. 726,0. 697 U/ml. The comparison of differences among the four groups was statistically significant (χ2=74. 046,P<0. 001). Pairwise comparisons among the four groups,and the differences between group B and group C were no significant,but specific IFN-γ content of the two groups was significantly higher than the other two groups,while the group D was higher than group A,the differences were statistically significant. The positive rate of IGRA was significantly higher than that of TST in group C(χ2=11. 314,P=0. 001). Conclusion: IGRA diagnosis in the application of immunocompromised patients with pulmonary tuberculosis was less affected by immune status and was more sensitive than TST,which can be used as auxiliary diagnosis.